Portfolio (Quarterly)
Guide ↗
Rangeley Capital, LLC
· CIK 0001517796| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | CWAN | CLEARWATER ANALYTICS HLDGS I | Technology | 28,000.0 | $662K | 0.64% | -52K | -65.0% | $23.65 | +2.8% |
| 42 | — | ROMAN DBDR ACQUISITION CORP | — | 60,000.0 | $628K | 0.61% | +17K | +38.9% | $10.47 | — |
| 43 | KROS | KEROS THERAPEUTICS INC | Healthcare | 54,400.0 | $601K | 0.58% | -42K | -43.8% | $11.04 | +1.4% |
| 44 | — | ENVIRI CORP | — | 28,000.0 | $549K | 0.53% | +17K | +162.5% | $19.62 | — |
| 45 | HEPS | D MARKET ELECTR SVCS & TRADI | Consumer Cyclical | 200,000.0 | $524K | 0.51% | — | — | $2.62 | +4.2% |
| 46 | BHR | BRAEMAR HOTELS & RESORTS INC | Real Estate | 222,000.0 | $524K | 0.51% | +148K | +200.4% | $2.36 | +5.5% |
| 47 | — | GENERAL PURP ACQUISITION COR | — | 50,000.0 | $500K | 0.49% | — | — | $10.01 | — |
| 48 | ABVX | ABIVAX SA | Healthcare | 4,000.0 | $445K | 0.43% | — | — | $111.35 | +9.6% |
| 49 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 27,016.0 | $444K | 0.43% | -40K | -60.0% | $16.45 | +14.3% |
| 50 | DSGR | DISTRIBUTION SOLUTIONS GRP I | Industrials | 16,857.0 | $442K | 0.43% | NEW | — | $26.24 | +2.9% |
| 51 | — | OAKTREE ACQUISITION CORP III | — | 61,188.0 | $424K | 0.41% | +21K | +52.9% | $6.92 | — |
| 52 | — | CORBUS PHARMACEUTICALS HLDGS | — | 44,840.0 | $421K | 0.41% | NEW | — | $9.39 | — |
| 53 | — | GLOBA TERRA ACQUISITION COR | — | 40,361.0 | $420K | 0.41% | — | — | $10.42 | — |
| 54 | — | NEW AMER ACQUISITION I CORP | — | 40,000.0 | $414K | 0.40% | — | — | $10.35 | — |
| 55 | IMMR | IMMERSION CORP | Technology | 75,000.0 | $410K | 0.40% | NEW | — | $5.46 | +14.8% |
| 56 | — | ONKURE THERAPEUTICS INC | — | 95,000.0 | $393K | 0.38% | -50K | -34.5% | $4.14 | — |
| 57 | STRS | STRATUS PPTYS INC | Real Estate | 12,546.0 | $383K | 0.37% | NEW | — | $30.52 | -5.2% |
| 58 | YEXT | YEXT INC | Technology | 99,328.0 | $381K | 0.37% | -486K | -83.0% | $3.84 | -4.2% |
| 59 | — | ADICET BIO INC | — | 56,000.0 | $381K | 0.37% | +31K | +124.0% | $6.81 | — |
| 60 | LSTA | LISATA THERAPEUTICS INC | Healthcare | 75,000.0 | $376K | 0.36% | NEW | — | $5.01 | -37.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
32.1%
Consumer Cyclical
23.4%
Real Estate
13.6%
Technology
9.2%
Financial Services
8.6%
Industrials
4.2%
Energy
3.9%
Communication Services
3.4%
Basic Materials
0.8%
Consumer Defensive
0.5%